
icon
-
Marc’s story: Raising awareness of elevated Lp(a) in cardiovascular disease
-
Giving voice to people with a misunderstood disease
-
Facing the fear of breast cancer recurrence
-
Shoulder to shoulder
-
Q&A: Addressing unmet needs for people living with PNH, a rare and chronic blood disorder
-
When you think of the word ‘cancer’, what are the first words that spring to mind?
-
Novartis Entresto® granted expanded indication in chronic heart failure by FDA
-
Breaking down barriers for patients with sickle cell disease
-
Sound Up for Lung Cancer
-
AveXis Announces Alignment with FDA on Next Steps Toward a BLA Submission for AVXS-101 in SMA Type 1
-
REGENXBIO and AveXis Announce Expansion of Relationship through Amended License Agreement for the Development and Commercialization of Treatments for Spinal Muscular Atrophy
-
AveXis Announces Expanded Clinical Development Program for AVXS-101 in Spinal Muscular Atrophy
Pagination
- ‹ Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- › Next page